Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Biagio De Angelis

Showing results (31-40 of 65) with videos related to

Pageof 7
Sort By:
Journal of Hematology & Oncology|November 13, 2021
Polymorphonuclear myeloid-derived suppressor cells impair the anti-tumor efficacy of GD2.CAR T-cells in patients with neuroblastomaNicola Tumino, Gerrit Weber, Francesca Besi, et al.
Blood|February 1, 2011
High-avidity cytotoxic T lymphocytes specific for a new PRAME-derived peptide can target leukemic and leukemic-precursor cellsConcetta Quintarelli, Gianpietro Dotti, Sayyeda T Hasan, et al.
Journal for Immunotherapy of Cancer|March 19, 2021
GD2 redirected CAR T and activated NK-cell-mediated secretion of IFNγ overcomes MYCN-dependent IDO1 inhibition, contributing to neuroblastoma cell immune escapeMatteo Caforio, Cristina Sorino, Ignazio Caruana, et al.
Oncoimmunology|June 7, 2018
Choice of costimulatory domains and of cytokines determines CAR T-cell activity in neuroblastomaConcetta Quintarelli, Domenico Orlando, Iolanda Boffa, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 5, 2026
An in vivo CRISPR screen unveils promising target genes to improve CAR-T cell efficacy in a solid tumor modelMattia Fumagalli, Dongjie An, Luca Simula, et al.
International Journal of Molecular Sciences|June 2, 2021
Establishment and Characterization of a Cell Line (S-RMS1) Derived from an Infantile Spindle Cell Rhabdomyosarcoma with <i>SRF-NCOA2</i> Fusion TranscriptMarta Colletti, Angela Galardi, Evelina Miele, et al.
Blood|March 3, 2026
Anti-CD7 fratricide-resistant chimeric antigen receptor T cells for relapsed/refractory acute myeloid leukemiaMarco Becilli, Pietro Merli, Mattia Algeri, et al.
Frontiers in Cell and Developmental Biology|February 9, 2023
Spermine oxidase induces DNA damage and sensitizes fusion negative rhabdomyosarcoma cells to irradiationClara Perrone, Silvia Pomella, Matteo Cassandri, et al.
Frontiers in Immunology|November 5, 2021
Inclusion of the Inducible Caspase 9 Suicide Gene in CAR Construct Increases Safety of CAR.CD19 T Cell Therapy in B-Cell MalignanciesMarika Guercio, Simona Manni, Iolanda Boffa, et al.
Cancers|July 2, 2021
Crosstalk between Macrophages and Myxoid Liposarcoma Cells Increases Spreading and Invasiveness of Tumor CellsMichele Minopoli, Sabrina Sarno, Lucia Cannella, et al.
Pageof 7

Showing results (31-40 of 65) with videos related to

Sort By:
Pageof 7
Journal of Hematology & Oncology|November 13, 2021
Polymorphonuclear myeloid-derived suppressor cells impair the anti-tumor efficacy of GD2.CAR T-cells in patients with neuroblastomaNicola Tumino, Gerrit Weber, Francesca Besi, et al.
Blood|February 1, 2011
High-avidity cytotoxic T lymphocytes specific for a new PRAME-derived peptide can target leukemic and leukemic-precursor cellsConcetta Quintarelli, Gianpietro Dotti, Sayyeda T Hasan, et al.
Journal for Immunotherapy of Cancer|March 19, 2021
GD2 redirected CAR T and activated NK-cell-mediated secretion of IFNγ overcomes MYCN-dependent IDO1 inhibition, contributing to neuroblastoma cell immune escapeMatteo Caforio, Cristina Sorino, Ignazio Caruana, et al.
Oncoimmunology|June 7, 2018
Choice of costimulatory domains and of cytokines determines CAR T-cell activity in neuroblastomaConcetta Quintarelli, Domenico Orlando, Iolanda Boffa, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 5, 2026
An in vivo CRISPR screen unveils promising target genes to improve CAR-T cell efficacy in a solid tumor modelMattia Fumagalli, Dongjie An, Luca Simula, et al.
International Journal of Molecular Sciences|June 2, 2021
Establishment and Characterization of a Cell Line (S-RMS1) Derived from an Infantile Spindle Cell Rhabdomyosarcoma with <i>SRF-NCOA2</i> Fusion TranscriptMarta Colletti, Angela Galardi, Evelina Miele, et al.
Blood|March 3, 2026
Anti-CD7 fratricide-resistant chimeric antigen receptor T cells for relapsed/refractory acute myeloid leukemiaMarco Becilli, Pietro Merli, Mattia Algeri, et al.
Frontiers in Cell and Developmental Biology|February 9, 2023
Spermine oxidase induces DNA damage and sensitizes fusion negative rhabdomyosarcoma cells to irradiationClara Perrone, Silvia Pomella, Matteo Cassandri, et al.
Frontiers in Immunology|November 5, 2021
Inclusion of the Inducible Caspase 9 Suicide Gene in CAR Construct Increases Safety of CAR.CD19 T Cell Therapy in B-Cell MalignanciesMarika Guercio, Simona Manni, Iolanda Boffa, et al.
Cancers|July 2, 2021
Crosstalk between Macrophages and Myxoid Liposarcoma Cells Increases Spreading and Invasiveness of Tumor CellsMichele Minopoli, Sabrina Sarno, Lucia Cannella, et al.
Pageof 7